Replies to post #74108 on Biotech Values

[DewDiligence]

HGSI – Every data point including side effects and dropout rates weren't in their favor.

The SVR rate is essentially the only metric that matters here; the relative tolerability of Albuferon vs Pegasys is subsumed within the respective ITT SVR rates.

Either way look for Albuferon to be a commercial flop.

It will need some creative marketing or a very aggressive price to gain significant traction.